
At the AIPPI World Congress in Hamburg, Koen Bijvank, a partner at Brinkhof, led the adoption of a resolution addressing double patenting and divisional applications in Europe. Bijvank, who also chaired the study committee on patents, outlined the key demands to JUVE Patent, emphasizing the resolution’s focus on procedural possibilities and double patenting issues. The resolution builds on AIPPI’s 2007 stance, reaffirming the organization’s commitment to addressing these challenges, particularly in the life sciences industry.
AIPPI’s stance on double patenting
According to Bijvank, AIPPI’s position is that double patenting is undesirable. The resolution states that in cases of double patenting, the issue must be resolved by amending or abandoning one of the patent applications. This stance aims to address the legal uncertainties surrounding divisional patent applications, which share the same filing date as their parent patents, making them exempt from novelty requirements. Bijvank explained that since divisional patents have the same filing date, the novelty requirement cannot prevent double patenting, necessitating a clear position on how to handle such cases.
The resolution also reaffirms AIPPI’s support for applicants’ rights to file divisional applications, a point of divergence among national groups during the submission process. AIPPI received 44 submissions from national groups and independent members, highlighting varying perspectives on the issue. Resolution Q193, adopted in 2007, focused on procedural aspects, while the new resolution Q297 specifically targets double patenting concerns related to divisional applications.
Practical implications and challenges
In his advisory practice, Bijvank encounters situations where a patent faces potential revocation while divisional applications remain pending. This creates uncertainty for third parties, as the original patent’s invalidation may not affect the divisional applications, which could protect similar inventions. Bijvank notes that while this issue is prominent in the life sciences sector, it can also arise in other industries, albeit less frequently. He added that patent owners often adjust divisional claims to improve their chances of surviving invalidity attacks, further complicating the environment.
Point 11 of the resolution addresses the “divisional game” debate, stating that there should be no restrictions on filing divisional applications to prevent abusive market behavior by patent holders. Bijvank suggests that existing procedural and competition laws in most jurisdictions can address such behavior, emphasizing that additional restrictions are unnecessary.
Implementing the resolution
AIPPI is taking steps to ensure its resolution is incorporated into national laws and the European Patent Convention. National groups are encouraged to share the resolution with lawmakers and governmental institutions involved in intellectual property protection. The resolution also serves as a basis for AIPPI’s contributions to WIPO Standing Committees and meetings of the B+ group of countries. Additionally, it informs position papers and submissions in response to consultations from intellectual property offices worldwide.
